To evaluate the contribution of the drug combination of omega-3, vitamin E, sodium selenite, copper gluconate, zinc gluconate, chondroitin sulfate, and glucosamine (Gerioox ® ), 12 dogs with chronic kidney disease (CKD) in outpatient clinical care at the veterinary hospital of a federal institution of higher education were studied. Complete blood counts, urinalyses, measurements of the serum concentration of calcium, phosphorus, urea and creatinine, and calculations of the urinary protein to creatinine ratio (UPC) and glomerular filtration rate (GFR) were performed before starting the experiment (T0) and after 30 (T1), 90 (T2), and 120 days (T3). There was a significant negative correlation (P<0.05) between the GFR and UPC and between the GFR and serum urea and creatinine (when the GFR was high, the UPC, serum urea and creatinine were decreased). Improvement was observed in the clinical status of the patients studied, as reported by their owners, who indicated improved vitality and appetite, and by clinical observation, which showed improvement in the overall health status, coat, and analyzed parameters. The combination of omega-3, vitamin E, sodium selenite, copper gluconate, zinc gluconate, chondroitin sulfate, and glucosamine found in Gerioox ® proved to be an important adjuvant in the conservative treatment of dogs with CKD, causing an increase in the GFR with a decrease in proteinuria. This result indicates that there was an improvement in the quality of excretion, not an increase in the excretion itself, which is a result of the undesired effect of increased glomerular pressure. Key words: Polyunsaturated fatty acids, kidneys, canine ResumoCom o objetivo de avaliar a contribuição da associação medicamentosa de ômega-3, vitamina E, selenito de sódio, gluconato de cobre, gluconato de zinco, sulfato de condroitina e glucosamina (Gerioox ® ), 12 cães oriundos do atendimento clínico ambulatorial do hospital veterinário de uma instituição federal de ensino superior, portadores de doença renal crônica (DRC), foram estudados. Foram realizados exames de hemograma, medida de concentração sérica de cálcio, fósforo, ureia e creatinina, urinálise, razão proteína creatinina urinária (RPC) e taxa de filtração glomerular (TFG) antes de iniciado o experimento (T0), após 30 (T1), 90 (T2) e 120 dias (T3). Houve correlação negativa significativa (P<0,05) entre a TFG e a RPC e a TFG e uréia e creatinina sérica (quando a TFG apresentava-se elevada, a RPC, assim como ureia e a creatinina séricas encontravam-se diminuídas). Houve melhora do estado clínico dos pacientes estudados observado pela sinalização dos tutores informando melhora da vitalidade e apetite e pelas observações clínicas de melhora do estado geral, da pelagem e dos parâmetros analisados. A associação de ômega-3, vitamina E, selenito de sódio, gluconato de cobre, gluconato de zinco, sulfato de condroitina e glucosamina revelou ser um importante coadjuvante no tratamento conservador da DRC de cães, causando aumento da TFG com diminuição da proteinúria, sign...
<p> </p><p><span><span>Para avaliar a contribuição da combinação de drogas de ômega-3, vitamina E, selenito de sódio, gluconato de cobre, gluconato de zinco, sulfato de condroitina, glucosamina e (Gerioox®), 12 cães com doença renal crônica (DRC) em atendimento clínico ambulatorial no Foram estudados hospital veterinário de uma instituição federal de ensino superior. </span><span>Contagens completas de sangue, urinálise, medições da concentração sérica de cálcio, fósforo, ureia e creatinina, e os cálculos da proteína urinária de creatinina (UPC) e taxa de filtração glomerular (TFG) foram realizados antes do início da experiência (T0) e depois 30 (T1), 90 (T2), e 120 dias (T3). </span><span>Houve uma correlação negativa significativa (P <0,05) entre o TFG ea UPC e entre o TFG ea uréia e creatinina séricas (quando a GFR foi alta, a UPC, uréia e creatinina séricas foram diminuídos). </span><span>A melhora foi observada no estado clínico dos pacientes estudados, conforme relatado pelos seus proprietários, que indicaram uma melhoria na vitalidade e apetite, e pela observação clínica, que mostrou melhora no estado geral de saúde, casaco, e os parâmetros analisados. </span><span>A combinação de omega-3, a vitamina E, o selenito de sódio, gluconato de cobre, gluconato de zinco, sulfato de condroitina, glucosamina e encontrado em Gerioox® provou ser um adjuvante importante no tratamento conservador de cães com DRC, causando um aumento na taxa de filtração glomerular com uma redução na proteinúria. </span><span>Este resultado indica que houve uma melhoria na qualidade de excreção, e não um aumento na excreção de si, o que é um resultado do efeito indesejado de aumento da pressão glomerular.</span></span></p>
In the search for an early biomarker of renal injury, this study aimed to determine the urinary protein profile of dogs with leishmaniasis without treatment and treated as determined by Brazilian legislation. The identification of proteinuria, its classification and the circumstances in which it takes place instigated this study. For this, 30 dogs from an outpatient clinic at a Veterinary Hospital in Belo Horizonte were evaluated. All animals underwent clinical and laboratory tests, which included renal biomarkers. The proteins were characterized using the SDS-page electrophoresis technique, and thus, a urinary protein profile was developed comparing patients considered clinically healthy with dogs infected with leishmaniasis that were under treatment and with untreated infected dogs. The results showed that the hematological and biochemical parameters showed similar behavior between the groups of healthy dogs and dogs with leishmaniasis treated, however a very heterogeneous pattern of urinary proteins can be observed and differed between healthy animals and animals with leishmaniasis, as well as between treated and untreated animals. The results suggest that the classification of proteinuria can be a tool that helps in the staging of animals infected with L. infantum and can differentiate them as to the severity of existing kidney injuries.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.